Eevia Health Plc: Eevia Health Plc Interim Report Q3 - 2024
The Board and CEO of Eevia Health Plc present the Interim financial report for quarter 3, 2024.Financial developments and significant events in the third quarter of 2024: • Net sales increased to KEUR 444 in Q3-24 from KEUR 410 in Q2-24, or 8%. Compared to Q3-24, net sales were down by KEUR 473 from KEUR 917, or 52%.• Gross profit in Q3-24 was KEUR 211, a decrease of 32% from KEUR 311 in Q2-24 and 39% from KEUR 348 in Q3-23. The gross margin was 46% in Q3-24, down from 76% in Q2-24 and up from 34% in Q3-23. The decline from Q2-24 was due to a change in product mix in sales and the